Results 51 to 60 of about 1,661 (172)

Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis

Gut Microbes, 2023
Cognitive dysfunction due to minimal hepatic encephalopathy (MHE) adversely impacts patients with cirrhosis and more precise therapies are needed. Gut-brain axis changes are therapeutic targets, but prior studies have largely focused on bacterial changes.
Thananya Jinato, Masoumeh Sikaroodi, Andrew Fagan, Richard K Sterling, Hannah Lee, Puneet Puri, Brian C Davis, Michael Fuchs, Edith Gavis, Patrick M Gillevet, Jasmohan S Bajaj   +10 more
doaj   +1 more source

Serum levels of neurofilament light chains in the detection of minimal hepatic encephalopathy in patients with liver cirrhosis

Egyptian Liver Journal
Background Minimal hepatic encephalopathy (MHE) is the mildest form of hepatic encephalopathy, often undetected in clinical practice, and reflects central nervous system dysfunction caused by liver disease and/or portosystemic shunting.
Moamena S. Elhamouly, Hosam E. Seleem, Sara M. El- Deeb, Eman M. Arab, Amany Abas Amer   +4 more
doaj   +1 more source

Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Portal Hypertension &Cirrhosis, Volume 4, Issue 4, Page 252-264, December 2025.
Hepatic encephalopathy (HE) is a frequent complication that arises subsequent to transjugular intrahepatic portosystemic shunt (TIPS) procedures, with a considerable impact on patient prognosis. The occurrence of HE is influenced by multiple factors, and various risk prediction models have been developed in recent years to forecast its development post‐
Lixin Song, Xinyi Qiao, Yu Sun, Hui Yang
wiley   +1 more source

QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis

JHEP Reports
Background & Aims: QuickStroop, a shortened version of the Stroop EncephalApp, has recently been proposed for screening for minimal hepatic encephalopathy (MHE) in patients with cirrhosis in the USA.
Christian Labenz, Simon J. Gairing, Leonard Kaps, Alena F. Ehrenbauer, Eva M. Schleicher, Sophie Mengel, Julius F.M. Egge, Maria M. Gabriel, Peter R. Galle, Heiner Wedemeyer, Alexander Zipprich, Cristina Ripoll, Robin Greinert, Benjamin Maasoumy   +13 more
doaj   +1 more source

Sex‐Specific Differences and a Predictive Model Based on Clinical and Biochemical Parameters for Minimal Hepatic Encephalopathy

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aims Minimal hepatic encephalopathy (MHE) affects 30%–40% of cirrhotic patients, showing cognitive and motor impairment, and affecting quality of life. MHE represents the earliest stage of hepatic encephalopathy, a condition with severe consequences. Assessing MHE from different perspectives, such as sex differences, can enhance
Juan José Gallego, Franc Casanova‐Ferrer, Alessandra Fiorillo, Salvador Benlloch, Amparo Urios, Adrià López‐Gramaje, María Oliver‐Ferrándiz, Lucía Durbán, María Pilar Ríos, Isabel Conde, Carmen Vinaixa, Victoria Aguilera, Teresa San‐Miguel, Javier Megías, Desamparados Escudero‐García, Elena Kosenko, Marina Berenguer, Carmina Montoliu   +17 more
wiley   +1 more source

The Prevalence and Association of Cognitive Impairment with Sleep Disturbances in Patients with Chronic Liver Disease

Brain Sciences, 2022
Introduction/Aim. The aim of this study was to assess the prevalence of cognitive impairments and their association with sleep patterns in a cohort of patients diagnosed with chronic liver disease (CLD). Material and methods.
Oana-Mihaela Plotogea, Camelia Cristina Diaconu, Gina Gheorghe, Madalina Stan-Ilie, Mircea-Alexandru Badea, Cristina Cijevschi Prelipcean, Gabriel Constantinescu   +6 more
doaj   +1 more source

[The Psychometric Score for Hepatic Encephalopathy and the Stroop EncephalApp in the diagnosis of covert hepatic encephalopathy in Cuba].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 2021
Introducción: El diagnóstico de la encefalopatía hepática encubierta en pacientes con cirrosis hepática se encuentra en estado de cambio, fundamentalmente en lo que a las pruebas diagnósticas refiere. Objetivo: El objetivo de este estudio fue comparar los resultados diagnósticos de dos test, el Score Psicométrico para Encefalopatía Hepática y el Stroop
openaire   +2 more sources

Modulation of neural activation following treatment of hepatic encephalopathy

, 2013
OBJECTIVE: To measure changes in psychometric state, neural activation, brain volume (BV), and cerebral metabolite concentrations during treatment of minimal hepatic encephalopathy.METHODS: As proof of principle, 22 patients with well-compensated, biopsy-
Dresner, M Alex, Saxby, Brian K, McPhail, Mark J W; id_orcid, Waldman, Adam D, Grover, Vijay P B, Crossey, Mary M E, Fitzpatrick, Julie A, Thomas, Howard C, Taylor-Robinson, Simon D, Wesnes, Keith, Pflugrad, Henning, Dhanjal, Novraj S, Leech, Robert   +12 more
core   +1 more source

A Study of Diagnosing Subclinical Hepatic Encephalopathy by Psychometric Tests in Patients with Cirrhosis [PDF]

, 2020
INTRODUCTION: Hepatic encephalopathy defines a wide array of subtle and transient reversible neuropsychiatric manifestations commonly encountered in patients living with cirrhosis. Subclinical hepatic encephalopathy which is defined as clinically normal
Devisaranya, S
core  

Data_Sheet_1_Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.docx

, 2023
BackgroundMinimal hepatic encephalopathy (MHE) is an early stage in the pathogenesis of hepatic encephalopathy. Intestinal microbiota is involved in the pathogenesis of hepatic encephalopathy and has become an important therapeutic target. Since there is
Wei-Juan Ma (14835430), Xiao-Han Ma (8830994), Ming-Wei Wang (51951), Yan Wang (15435), Yu-Feng Xue (14835433), Jing Guan (335452), Xi Chen (35903)   +6 more
core   +1 more source